genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
ViroPharma
News
Shire Expects Slower 2015 Sales Growth
News
Shire Buys ViroPharma for $4.2M, Expanding Rare Disease Holdings
Industry News
ViroPharma Pays Meritage Initial $7.5M for Option to Acquire Firm for EoE Drug
Industry News
EC Sanction of DuoCort’s Plenadren Triggers ViroPharma’s $33M Acquisition of Swedish Firm
Industry News
ViroPharma Will Buy DuoCort for $33.6M Up Front if EU-Filed Hydrocortisone Drug Is Approved
Drug Discovery
ViroPharma Gives Intellect Neurosciences $6.5M for Exclusive Worldwide Rights to OX1
Drug Discovery
ViroPharma Licenses Halozyme’s Hyaluronidase for $9M to Develop Subcutaneous Cinryze
News
Evotec Inks Anemia Drug Discovery Agreement with Vifor Pharma
News
FDA Requires More Data to Approve ViroPharma’s Drug for Acute Treatment of Angioedema
News
ViroPharma to Purchase Lev for $442.9M
Scroll Up
Scroll Up
